ESR1 and triple-negative breast carcinoma: Similarly, studies on canines with malignant mammary tumors have applied analogous markers, revealing that tumors lacking ER and PR generally exhibit poorer outcomes, akin to triple-negative breast cancer in humans, which is characterized as an aggressive disease, with poor prognosis [83,84,85].